Our Record

• 34 years Phase 1 experience
• 420 dedicated beds
• 0 Major findings in 60 GCP inspections
• 25,000+ Healthy Young Japanese Male/Female, 2,600+ Healthy Elderly Japanese Male/ Female, 550+ Healthy Young Caucasian Male/Female, 200+ Healthy Korean Male, 200+ Healthy Chinese Male, Patients

Our Studies

Top 3 Study Therapeutic Areas

Other Study Therapeutic Areas: Genitourinary, Dermatology, Vaccine, Gastroenterology, Endocrinology, Allergology, Chemotherapeutics, Antibiotic, PNS, Biosimilar, and more…

Our Clients

Out of the World Top 100 Pharmaceutical Companies by revenue in 2018 (Source: Novasecta), nearly half of the companies including 17 Japanese Major Pharma have chosen us as their study site!!